Login
Evidence Feed
About
Diagnostics
New
FAQ
Contact us
^
Login
Contact us
to learn more about
our Premium Content: News alerts, weekly reports and conference planners
BIOMARKER:
EGFR L858R + KDR overexpression + VEGFC overexpression
i
Other names:
EGFR, ERBB, ERBB1, Epidermal growth factor receptor, KDR, CD309, FLK1, VEGFR, VEGFR2, Kinase insert domain receptor (a type III receptor tyrosine kinase), VEGFC, Vascular Endothelial Growth Factor C, Vascular Endothelial Growth Factor-Related Protein, VRP, Flt4-L, VEGF-C, FLT4 Ligand DHM, Flt4 Ligand, LMPH1D, LMPHM4
Contact us
to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Entrez ID:
1956
;
3791
;
7424
Related biomarkers:
Expression
Mutation
CNA
Fusion
Others
‹
EGFR-RAD51 fusion (5)
EGFR-SEPTIN14 fusion (2)
EGFR fusion (1)
EGFR-GRB2 fusion (1)
KIF5B-EGFR fusion (1)
EGFR fusion + RAD51 fusion (0)
EGFR-RAD51 fusion (5)
EGFR-SEPTIN14 fusion (2)
EGFR fusion (1)
EGFR-GRB2 fusion (1)
KIF5B-EGFR fusion (1)
EGFR fusion + RAD51 fusion (0)
›
Associations
News
Trials
VERI cancer hierarchy
Reset Filters
EGFR L858R + KDR overexpression + VEGFC overexpression
Non Small Cell Lung Cancer
EGFR L858R + KDR overexpression + VEGFC overexpression
Non Small Cell Lung Cancer
osimertinib
Resistant: C3 – Early Trials
osimertinib
Resistant
:
C3
osimertinib
Resistant: C3 – Early Trials
osimertinib
Resistant
:
C3
^
^
×
Unlock More with VERI
Sign up to access premium content
Email *
Password *
Confirm Password *
I'm not a robot
Please register with your email ID.
×
Unlock More with VERI
Sign up to access premium content
Email *
Password *
Confirm Password *
I'm not a robot
Please register with your email ID.